美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=NDA022580"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
62541-202-30 62541-202 HUMAN PRESCRIPTION DRUG Qsymia phentermine and topiramate CAPSULE, EXTENDED RELEASE ORAL 20120917 N/A NDA NDA022580 Vivus LLC PHENTERMINE HYDROCHLORIDE; TOPIRAMATE 7.5 mg/1; 46 mg/1 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, UNIT-DOSE (62541-202-30)
62541-204-30 62541-204 HUMAN PRESCRIPTION DRUG Qsymia phentermine and topiramate CAPSULE, EXTENDED RELEASE ORAL 20120917 N/A NDA NDA022580 Vivus LLC PHENTERMINE HYDROCHLORIDE; TOPIRAMATE 15 mg/1; 92 mg/1 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, UNIT-DOSE (62541-204-30)
62541-201-14 62541-201 HUMAN PRESCRIPTION DRUG Qsymia phentermine and topiramate CAPSULE, EXTENDED RELEASE ORAL 20120917 N/A NDA NDA022580 Vivus LLC PHENTERMINE HYDROCHLORIDE; TOPIRAMATE 3.75 mg/1; 23 mg/1 14 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, UNIT-DOSE (62541-201-14)
62541-201-30 62541-201 HUMAN PRESCRIPTION DRUG Qsymia phentermine and topiramate CAPSULE, EXTENDED RELEASE ORAL 20120917 N/A NDA NDA022580 Vivus LLC PHENTERMINE HYDROCHLORIDE; TOPIRAMATE 3.75 mg/1; 23 mg/1 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, UNIT-DOSE (62541-201-30)
62541-203-30 62541-203 HUMAN PRESCRIPTION DRUG Qsymia phentermine and topiramate CAPSULE, EXTENDED RELEASE ORAL 20120917 N/A NDA NDA022580 Vivus LLC PHENTERMINE HYDROCHLORIDE; TOPIRAMATE 11.25 mg/1; 69 mg/1 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62541-203-30)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase